/Companies

Diagnóstica Longwood

1 known investors

Find your way into Diagnóstica Longwood

Sign up to see every warm intro you have to Diagnóstica Longwood

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Diagnóstica Longwood team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Diagnóstica Longwood is a distributor of in vitro diagnostics technologies, supplying NGS-based assays, kits and reagents for molecular diagnostics in areas such as oncology, hereditary and rare diseases, and microbiology. Founded in 1992, it serves clinical and research laboratories with technical support and its own inventory in Spain.

Investors · 1

Frequently asked questions

What does Diagnóstica Longwood do?
Diagnóstica Longwood is a distributor of in vitro diagnostics technologies, supplying NGS-based assays, kits and reagents for molecular diagnostics in areas such as oncology, hereditary and rare diseases, and microbiology. Founded in 1992, it serves clinical and research laboratories with technical support and its own inventory in Spain.
Who are Diagnóstica Longwood's investors?
Diagnóstica Longwood's investors include Apheon.